Johnson & Johnson opens new Asia Pacific headquarters

pharmafield logo - pharma news

Johnson & Johnson Asia Pacific Pte Ltd have announced the official opening of its new Asia Pacific headquarters, reaffirming its commitment to advancing healthcare innovation in Singapore and the Asia Pacific region. The regional headquarters will lead collaborations and partnerships to co-create new global healthcare models which are at the forefront of innovation.

The new 15,800 sq. meter facility will bring together more than 1,000 employees from Johnson & Johnson’s pharmaceuticals, medical devices and consumer businesses in one single location to spearhead new ideas and frameworks for healthcare of the future.

The regional headquarters will boast a Design Lab, Leadership Lab, and Human Performance Institute. Johnson & Johnson’s Asia Design Lab will be the first design lab outside of the United States.

Singapore has also been selected as the location for Johnson & Johnson’s first global development center known as the Leadership Lab. The Leadership Lab aims to conduct over 200 leadership development classes and train 4,000 Asian leaders annually. As a think-tank, the Leadership Lab will create links with universities, research groups, governments, healthcare organizations and other partners to co-create new healthcare models and solutions.

The regional headquarters will also include Asia Pacific’s first Human Performance Institute (HPI). A first of its kind in Asia Pacific, HPI will offer its proprietary leadership development initiatives to participants outside of Johnson & Johnson, with the goal to train 150,000 people in Singapore by 2020.

Ms. Ai Hua Ong, Company Group Chair, Janssen, the pharmaceutical companies of Johnson & Johnson said, “The shifts in population demographics, globalization and technology today require companies to move health forward faster than ever before. We believe that our new regional hub in Singapore coupled with our global scientific strength and strategic external collaborations will create enduring and impactful solutions that reimagine the future of health.”